Literature DB >> 6309178

Specific binding of luteinizing hormone releasing hormone to human luteal tissue.

R Popkin, T A Bramley, A Currie, R W Shaw, D T Baird, H M Fraser.   

Abstract

Homogenates of human luteal tissue bound radioiodinated luteinizing hormone releasing hormone agonist. Specific binding was both time- and temperature-dependent. Native LHRH and two LHRH agonists competed for binding, whereas TRH, somatostatin and oxytocin did not, indicating that the binding sites were specific. The apparent Ka values were 2 X 10(7)M-1 for both LHRH agonists and 10(6)M-1 for native LHRH. This is the first demonstration of specific binding of LHRH to human ovarian tissue. No binding could be detected to ovarian tissue from postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309178     DOI: 10.1016/0006-291x(83)90844-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Spatial proteomics: a powerful discovery tool for cell biology.

Authors:  Emma Lundberg; Georg H H Borner
Journal:  Nat Rev Mol Cell Biol       Date:  2019-05       Impact factor: 94.444

2.  LRFD6a has a dose-related stimulatory or inhibitory effect on the ovary in normal luteal phase women.

Authors:  E R Barnea; R Maheux; B V Caldwell; J DeFazio; A H DeCherney; F Naftolin
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

Review 3.  GnRH and its analogues. Current therapeutic applications and new prospects.

Authors:  H M Fraser
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

4.  Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.

Authors:  M I Hsu; P Kolm; J Leete; K W Dong; S Muasher; S Oehninger
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

5.  The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).

Authors:  Y Gonen; M Dirnfeld; S Goldman; M Koifman; H Abramovici
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-10

Review 6.  Harnessing non-destructive 3D pathology.

Authors:  Jonathan T C Liu; Adam K Glaser; Kaustav Bera; Lawrence D True; Nicholas P Reder; Kevin W Eliceiri; Anant Madabhushi
Journal:  Nat Biomed Eng       Date:  2021-02-15       Impact factor: 25.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.